Validity of the Health Improvement Network (THIN) for the study of psoriasis

British Journal of Dermatology

Volumn 164, Issue 3, 2011, Pages 602-609

  Seminara, N M ^a   Abuabara, K ^a   Shin, D B ^a   Langan, S M ^a   Kimmel, S E ^a   Margolis, D ^a   Troxel, A B ^a   Gelfand, J M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CLINICAL CLASSIFICATION; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC VALUE; DISEASE DURATION; FACTUAL DATABASE; FEMALE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MEDICAL RECORD; MEDICAL SPECIALIST; PATIENT REFERRAL; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; SCHOOL CHILD; THE HEALTH IMPROVEMENT NETWORK; VALIDITY;

AGE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; EPIDEMIOLOGIC METHODS; FEMALE; GREAT BRITAIN; HUMANS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; PREVALENCE; PSORIASIS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 79952384260     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.10134.x     Document Type: Article

References (31)

1. Kurd SK, Gelfand JM,. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol 2009; 60: 218-24.
2. Koo J,. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin 1996; 14: 485-96. (Pubitemid 26249398)
3. Stern RS, Nijsten T, Feldman SR, et al. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004; 9: 136-9. (Pubitemid 38457271)
4. Gelfand JM, Weinstein R, Porter SB, et al. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005; 141: 1537-41. (Pubitemid 41815843)
5. Gelfand JM, Wang X, Qing L, et al. Epidemiology and treatment patterns of psoriasis in the General Practice Research Database (GPRD). Pharmacoepidemiol Drug Saf 2005; 14 (Suppl.): S23-4 [Abstr.]
6. Nevitt GJ, Hutchinson PE,. Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease. Br J Dermatol 1996; 135: 533-7. (Pubitemid 26340262)
7. Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-41. (Pubitemid 44547793)
8. Gelfand JM, Dommasch ED, Shin DB, et al. The risk of stroke in patients with psoriasis. J Invest Dermatol 2009; 129: 2411-18.
9. Gelfand JM, Troxel AB, Lewis JD, et al. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 2007; 143: 1493-9. (Pubitemid 350277763)
10. Mehta NN, Azfar RS, Shin DB, et al. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J 2010; 31: 1000-6.
11. Cohen AD, Sherf M, Vidavsky L, et al. Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology 2008; 216: 152-5. (Pubitemid 351158580)
12. Brauchli YB, Jick SS, Miret M, et al. Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol 2009; 160: 1048-56.
13. Kimball AB, Robinson D Jr, Wu Y, et al. Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002. Dermatology 2008; 217: 27-37. (Pubitemid 351896565)
14. Prodanovich S, Kirsner RS, Kravetz JD, et al. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol 2009; 145: 700-3.
15. Abuabara K, Azfar RS, Shin DB, et al. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol 2010; 163: 586-92.
16. Strom BL,. Pharmacoepidemiology, 4th edn. Chichester: John Wiley & Sons, 2005.
17. Gelfand JM, Azfar RS, Mehta NN,. Psoriasis and cardiovascular risk: strength in numbers. J Invest Dermatol 2010; 130: 919-22.
18. Rawson NS, D'Arcy C,. Assessing the validity of diagnostic information in administrative health care utilization data: experience in Saskatchewan. Pharmacoepidemiol Drug Saf 1998; 7: 389-98. (Pubitemid 29047895)
19. Neimann AL, Shin DB, Wang X, et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829-35. (Pubitemid 44556851)
20. Gelfand JM, Berlin J, van Voorhees A, et al. Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom. Arch Dermatol 2003; 139: 1425-9. (Pubitemid 37433132)
21. Huerta C, Rivero E, Rodriguez LA,. Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007; 143: 1559-65. (Pubitemid 350277774)
22. EPIC. THIN Data From EPIC: A Guide For Researchers. London: EPIC, 2007.
23. Margulis AV, Garcia Rodriguez LA, Hernandez-Diaz S,. Positive predictive value of computerized medical records for uncomplicated and complicated upper gastrointestinal ulcer. Pharmacoepidemiol Drug Saf 2009; 18: 900-9.
24. Meal A, Leonardi-Bee J, Smith C, et al. Validation of THIN data for non-melanoma skin cancer. Qual Prim Care 2008; 16: 49-52. (Pubitemid 351454579)
25. Hall GC,. Validation of death and suicide recording on the THIN UK primary care database. Pharmacoepidemiol Drug Saf 2009; 18: 120-31.
26. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 2007; 18: 800-4. (Pubitemid 350295184)
27. Cai B,. An algorithm to identify practices common to both the GPRD and THIN database. Pharmacoepidemiol Drug Saf 2010; 19: S86.
28. Choi BC,. Slopes of a receiver operating characteristic curve and likelihood ratios for a diagnostic test. Am J Epidemiol 1998; 148: 1127-32. (Pubitemid 28562173)
29. Hanley JA, McNeil BJ,. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36. (Pubitemid 12142173)
30. Landis JR, Koch GG,. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74. (Pubitemid 8054849)
31. Basarab T, Munn SE, Jones RR,. Diagnostic accuracy and appropriateness of general practitioner referrals to a dermatology out-patient clinic. Br J Dermatol 1996; 135: 70-3. (Pubitemid 26225118)